Cargando…

Reduced-cost Chlamydia trachomatis-specific multiplex real-time PCR diagnostic assay evaluated for ocular swabs and use by trachoma research programmes

INTRODUCTION: Trachoma, caused by the intracellular bacterium Chlamydia trachomatis (Ct), is the leading infectious cause of preventable blindness. Many commercial platforms are available that provide highly sensitive and specific detection of Ct DNA. However, the majority of these commercial platfo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Butcher, Robert, Houghton, Jo, Derrick, Tamsyn, Ramadhani, Athumani, Herrera, Beatriz, Last, Anna R., Massae, Patrick A., Burton, Matthew J., Holland, Martin J., Roberts, Chrissy h.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Biomedical 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496587/ https://www.ncbi.nlm.nih.gov/pubmed/28487054 http://dx.doi.org/10.1016/j.mimet.2017.04.010

Ejemplares similares

The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment
por: Ramadhani, Athumani M., et al.
Publicado: (2016)

miRNAs that associate with conjunctival inflammation and ocular Chlamydia trachomatis infection do not predict progressive disease
por: Derrick, Tamsyn, et al.
Publicado: (2017)

Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community
por: Ramadhani, Athumani M., et al.
Publicado: (2019)

Immunofibrogenic Gene Expression Patterns in Tanzanian Children with Ocular Chlamydia trachomatis Infection, Active Trachoma and Scarring: Baseline Results of a 4-Year Longitudinal Study
por: Ramadhani, Athumani M., et al.
Publicado: (2017)

DjinniChip: evaluation of a novel molecular rapid diagnostic device for the detection of Chlamydia trachomatis in trachoma-endemic areas
por: Derrick, Tamsyn R., et al.
Publicado: (2020)

Viability PCR shows that non-ocular surfaces could contribute to transmission of Chlamydia trachomatis infection in trachoma
por: Versteeg, Bart, et al.
Publicado: (2020)

Trachoma: Protective and Pathogenic Ocular Immune Responses to Chlamydia trachomatis
por: Hu, Victor H., et al.
Publicado: (2013)

Trachoma and Ocular Chlamydial Infection in the Era of Genomics
por: Derrick, Tamsyn, et al.
Publicado: (2015)

Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease
por: Ramadhani, Athumani M., et al.
Publicado: (2016)

Evaluation of a Chlamydia trachomatis-specific, commercial, real-time PCR for use with ocular swabs
por: Pickering, Harry, et al.
Publicado: (2018)

Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji
por: Macleod, Colin K., et al.
Publicado: (2016)

Spatial clustering of high load ocular Chlamydia trachomatis infection in trachoma: a cross-sectional population-based study
por: Last, Anna, et al.
Publicado: (2017)

Conjunctival transcriptome profiling of Solomon Islanders with active trachoma in the absence of Chlamydia trachomatis infection
por: Vasileva, Hristina, et al.
Publicado: (2018)

Progression of scarring trachoma in Tanzanian children: A four-year cohort study
por: Ramadhani, Athumani M., et al.
Publicado: (2019)

Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020?
por: Harding-Esch, Emma M., et al.
Publicado: (2009)

Inverse relationship between microRNA-155 and -184 expression with increasing conjunctival inflammation during ocular Chlamydia trachomatis infection
por: Derrick, Tamsyn, et al.
Publicado: (2016)

Trachoma, Anti-Pgp3 Serology, and Ocular Chlamydia trachomatis Infection in Papua New Guinea
por: Macleod, Colin K, et al.
Publicado: (2020)

Risk Factors for Active Trachoma and Ocular Chlamydia trachomatis Infection in Treatment-Naïve Trachoma-Hyperendemic Communities of the Bijagós Archipelago, Guinea Bissau
por: Last, Anna R., et al.
Publicado: (2014)

The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children
por: Pickering, Harry, et al.
Publicado: (2022)

Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis
por: Butcher, Robert, et al.
Publicado: (2018)

Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati
por: Cama, Anaseini, et al.
Publicado: (2017)

Development and Evaluation of a Next-Generation Digital PCR Diagnostic Assay for Ocular Chlamydia trachomatis Infections
por: Roberts, Chrissy h., et al.
Publicado: (2013)

Immunopathogenesis of Progressive Scarring Trachoma: Results of a 4-Year Longitudinal Study in Tanzanian Children
por: Derrick, Tamsyn, et al.
Publicado: (2020)

Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma
por: Butcher, Robert, et al.
Publicado: (2020)

Detecting extra-ocular Chlamydia trachomatis in a trachoma-endemic community in Ethiopia: Identifying potential routes of transmission
por: Last, Anna, et al.
Publicado: (2020)

Differential frequency of NKG2C/KLRC2 deletion in distinct African populations and susceptibility to Trachoma: a new method for imputation of KLRC2 genotypes from SNP genotyping data
por: Goncalves, Adriana, et al.
Publicado: (2016)

Genomics of Ocular Chlamydia trachomatis After 5 Years of SAFE Interventions for Trachoma in Amhara, Ethiopia
por: Pickering, Harry, et al.
Publicado: (2020)

The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa
por: Last, Anna R., et al.
Publicado: (2017)

Chlamydia trachomatis ompA Variants in Trachoma: What Do They Tell Us?
por: Andreasen, Aura A., et al.
Publicado: (2008)

Can corneal pannus with trachomatous inflammation – follicular be used in combination as an improved specific clinical sign for current ocular Chlamydia trachomatis infection?
por: Derrick, Tamsyn, et al.
Publicado: (2016)

Natural Products for the Treatment of Trachoma and Chlamydia trachomatis
por: Potroz, Michael G., et al.
Publicado: (2015)

Plasmid Copy Number and Disease Severity in Naturally Occurring Ocular Chlamydia trachomatis Infection
por: Last, Anna R., et al.
Publicado: (2014)

Population-based analysis of ocular Chlamydia trachomatis in trachoma-endemic West African communities identifies genomic markers of disease severity
por: Last, A. R., et al.
Publicado: (2018)

The Easiest Children to Reach Are Most Likely to Be Infected with Ocular Chlamydia trachomatis in Trachoma Endemic Areas of Niger
por: Amza, Abdou, et al.
Publicado: (2013)

Conjunctival FOXP3 Expression in Trachoma: Do Regulatory T Cells Have a Role in Human Ocular Chlamydia trachomatis Infection?
por: Faal, Nkoyo, et al.
Publicado: (2006)

Estimating Household and Community Transmission of Ocular Chlamydia trachomatis
por: Blake, Isobel M., et al.
Publicado: (2009)

Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon Islands
por: Butcher, Robert M. R., et al.
Publicado: (2016)

Population-Based Prevalence of Ocular Chlamydia trachomatis Infection among Infants in the Trachoma Endemic Amhara Region, Ethiopia
por: Nash, Scott D., et al.
Publicado: (2022)

Prevalence of Ocular Chlamydia trachomatis Infection in Amhara Region, Ethiopia, after 8 Years of Trachoma Control Interventions
por: Nash, Scott D., et al.
Publicado: (2023)

Correction: Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon Islands
por: Butcher, Robert M. R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f3rtt6dohk0t9jgr8ppcnahto0